Abstract 1593MO
Background
Effective interventions to improve prognosis in non-small-cell lung cancer (NSCLC) are urgently needed. We assessed the effect of the early integration of interdisciplinary palliative care (based on Ewarm model) for patients with NSCLC on the quality of life (QoL), psychological state, cancer pain and nutritional status.
Methods
In this randomised controlled trial, 280 newly diagnosed NSCLC patients were enrolled and randomly assigned (1:1) to the combined early palliative care (CEPC) group integrated with standard oncologic care or standard oncological care (SC) group. QoL and psychological state were assessed at baseline and at 24 weeks by Functional Assessment of Cancer Therapy-Lung (FACT-L) scale, the Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire-9 (PHQ-9), respectively. Cancer nutritional and pain status were assessed with the use of the Patient-Generated Subjective Global Assessment (PG-SGA) and Numerical Rating Scale (NRS), respectively. The primary end point was overall survival (OS). The second end point was the change in the quality of life, psychological state, pain and nutritional status at 24 weeks. Analysis was by intention to treat.
Results
280 patients were enrolled: 140 in CEPC group (102 completed) and 140 in the SC group (82 completed). CEPC group had a better QoL than SC group (all P < 0.05). In addition, fewer patients in the CEPC group than in the SC group had depressive (P < 0.05) symptoms. Furthermore, patients in CEPC group had a better nutritional status and pain than SC group (P =0.007 and P =0.003). Patients in the CEPC group had significantly longer survival than those in the SC group (median OS, 24.6 vs. 20.4 months; P=0.042) (HR, 0.19; 95% CI, 0.04 to 0.85; P=0.029).
Conclusions
Among patients with non-small-cell lung cancer, early palliative care led to significant improvements in longer survival, quality of life, psychological state, pain and nutritional status.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2032MO - Correlation of safety and efficacy in atezolizumab therapy across indications
Presenter: Jarushka Naidoo
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1843MO - The effect of chronic psychological stress on the efficacy of first-line therapy of ICIs in advanced NSCLC (STRESS-LUNG-1 trial)
Presenter: Fang Wu
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
2033MO - The impact of proton pump inhibitor (PPI) exposure before immune checkpoint inhibitor (ICI) therapy on overall survival (OS): A population-based study
Presenter: Lawson Eng
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 2032MO, 1843MO, 2033MO
Presenter: Christina Ruhlmann
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Webcast
LBA96 - Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study
Presenter: Shun Lu
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
LBA97 - Olanzapine for the prevention of chemotherapy induced nausea vomiting in patients receiving moderately emetogenic chemotherapeutic (MEC) regimens: Results of a prospective triple blinded phase III multicentric study (OMEC)
Presenter: Vikas Ostwal
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1844MO - Association of peripheral blood leukocyte DNA methylation profiles with the development of depressive symptoms in lung cancer patients undergoing systemic therapy
Presenter: Angelika Starzer
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA96, LBA97 and 1844MO
Presenter: Karin Jordan
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Webcast
1592MO - Anticancer therapy at the end-of-life: A cluster-randomized trial
Presenter: Marianne Hjermstad
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
2034MO - EAGER: A randomized, controlled, multicenter trial of electro-acupuncture in gastric cancer patients undergoing adjuvant chemotherapy
Presenter: Hai-bo Zhang
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast